User profiles for David L Paterson

David L. Paterson

University of Queensland
Verified email at uq.edu.au
Cited by 114585

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

…, L Moja, B Ndoye, A Pan, DL Paterson… - The Lancet infectious …, 2018 - thelancet.com
Background The spread of antibiotic-resistant bacteria poses a substantial threat to morbidity
and mortality worldwide. Due to its large public health and societal implications, multidrug-…

[HTML][HTML] Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

…, S Mushtaq, T Noorie, DL Paterson… - The Lancet infectious …, 2010 - thelancet.com
Background Gram-negative Enterobacteriaceae with resistance to carbapenem conferred
by New Delhi metallo-β-lactamase 1 (NDM-1) are potentially a major global health problem. …

Extended-spectrum β-lactamases: a clinical update

DL Paterson, RA Bonomo - Clinical microbiology reviews, 2005 - Am Soc Microbiol
Extended-spectrum β-lactamases (ESBLs) are a rapidly evolving group of β-lactamases
which share the ability to hydrolyze third-generation cephalosporins and aztreonam yet are …

Acinetobacter baumannii: Emergence of a Successful Pathogen

AY Peleg, H Seifert, DL Paterson - Clinical microbiology reviews, 2008 - Am Soc Microbiol
Acinetobacter baumannii has emerged as a highly troublesome pathogen for many institutions
globally. As a consequence of its immense ability to acquire or upregulate antibiotic drug …

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

DL Paterson, S Swindells, J Mohr, M Brester… - Annals of internal …, 2000 - acpjournals.org
Background: Combination antiretroviral therapy with protease inhibitors has transformed HIV
infection from a terminal condition into one that is manageable. However, the complexity of …

Antimicrobial resistance in ESKAPE pathogens

…, MA Schembri, SA Beatson, DL Paterson… - Clinical microbiology …, 2020 - Am Soc Microbiol
Antimicrobial-resistant ESKAPE ( Enterococcus faecium , Staphylococcus aureus , Klebsiella
pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacter …

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

…, P Nordmann, JB Patel, DL Paterson… - The Lancet infectious …, 2013 - thelancet.com
Klebsiella pneumoniae carbapenemases (KPCs) were originally identified in the USA in
1996. Since then, these versatile β-lactamases have spread internationally among Gram-…

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance …

…, JP Burke, WC Huskins, DL Paterson… - Clinical infectious …, 2007 - academic.oup.com
This document presents guidelines for developing institutional programs to enhance
antimicrobial stewardship, an activity that includes appropriate selection, dosing, route, and …

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

…, K Coulthard, CR Rayner, DL Paterson - The Lancet infectious …, 2006 - thelancet.com
Increasing multidrug resistance in Gram-negative bacteria, in particular Pseudomonas
aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae, presents a critical problem. …

Resistance in gram-negative bacteria: Enterobacteriaceae

DL Paterson - American journal of infection control, 2006 - Elsevier
The emergence and spread of resistance in Enterobacteriaceae are complicating the
treatment of serious nosocomial infections and threatening to create species resistant to all …